COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value (COLL)

Historical Holders from Q2 2015 to Q1 2025

Symbol
COLL on Nasdaq
CUSIP
19459J104
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
32.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
37.1M
Holdings value
$1.06B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
239
Number of buys
99
Number of sells
-136
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value (COLL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rubric Capital Management LP 7.29% $70.1M 2.35M Rubric Capital Management LP Dec 31, 2024
Invesco Ltd. 5.5% $53M 1.78M Invesco Ltd. Dec 31, 2024
RENAISSANCE TECHNOLOGIES LLC 5.14% $49.4M 1.66M Renaissance Technologies LLC Aug 2, 2024

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value (COLL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 470K $14M -$1.68M $29.85 25
2024 Q4 37.1M $1.06B -$53.7M $28.65 239
2024 Q3 38.5M $1.49B -$25.9M $38.64 249
2024 Q2 39.6M $1.28B -$75.9M $32.20 230
2024 Q1 15.8M $611M +$3.44M $38.82 104
2023 Q4 38.9M $1.2B +$2.8M $30.78 188
2023 Q3 38.7M $865M -$13.2M $22.35 173
2023 Q2 39.2M $843M +$2.46M $21.49 177
2023 Q1 39M $937M +$74.1M $23.99 196
2022 Q4 35.9M $833M +$6.7M $23.20 170
2022 Q3 35.4M $567M -$20M $16.02 152
2022 Q2 36M $638M +$14.3M $17.72 149
2022 Q1 35.8M $728M +$7.11M $20.36 158
2021 Q4 35.6M $664M -$14.4M $18.68 148
2021 Q3 36.4M $719M -$39M $19.74 149
2021 Q2 38M $897M -$28.8K $23.64 154
2021 Q1 38M $901M +$56.4M $23.70 161
2020 Q4 35.8M $718M -$716K $20.03 132
2020 Q3 37.3M $776M +$4.08M $20.82 136
2020 Q2 37M $647M +$3.8M $17.50 148
2020 Q1 36.9M $602M +$85.1M $16.33 154
2019 Q4 31.5M $648M +$50.5M $20.58 133
2019 Q3 30M $345M -$4.71M $11.48 116
2019 Q2 30.3M $399M -$8.93M $13.15 124
2019 Q1 30.8M $467M -$36.7M $15.14 136
2018 Q4 33M $567M +$7.94M $17.17 115
2018 Q3 30.4M $448M +$12M $14.74 117
2018 Q2 29.1M $694M +$15.8M $23.85 127
2018 Q1 30.3M $773M +$49.3M $25.55 133
2017 Q4 28.5M $526M +$70.8M $18.46 99
2017 Q3 26M $273M +$14.2M $10.49 74
2017 Q2 24.5M $307M +$19.6M $12.51 68
2017 Q1 23.3M $235M +$9.38M $10.06 79
2016 Q4 23.3M $363M +$116M $15.57 85
2016 Q3 15.9M $306M +$29.4M $19.26 70
2016 Q2 14.6M $173M -$10.8M $11.85 72
2016 Q1 14.9M $269M +$53.1M $18.15 68
2015 Q4 11.9M $327M +$13.5M $27.50 57
2015 Q3 8.69M $192M +$23M $22.11 44
2015 Q2 9.28M $165M +$138M $17.84 45